Clinical Trial Update: Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MRI-guided adaptive radiation therapy with concurrent chemotherapy and consolidation durvalumab in inoperable Stage IIB to IIIC non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stage Iib Non-small Cell Lung Cancer
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer
• Stage Iiic Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Stage IIB Non-Small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED